Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/08/22
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated MilestonesGlobeNewsWire • 11/08/22
Sutro Biopharma Announces Oral Presentation at the 64th American Society of Hematology Annual Meeting and ExpositionGlobeNewsWire • 11/03/22
Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 11/02/22
Wall Street Analysts Believe Sutro Biopharma, Inc. (STRO) Could Rally 326%: Here's is How to TradeZacks Investment Research • 10/21/22
Does Sutro Biopharma, Inc. (STRO) Have the Potential to Rally 293% as Wall Street Analysts Expect?Zacks Investment Research • 10/05/22
How Much Upside is Left in Sutro Biopharma, Inc. (STRO)? Wall Street Analysts Think 288%Zacks Investment Research • 08/29/22
Wall Street Analysts Think Sutro Biopharma, Inc. (STRO) Could Surge 295%: Read This Before Placing a BetZacks Investment Research • 08/11/22
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/08/22
Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated MilestonesGlobeNewsWire • 08/08/22
Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives Collaboration with MerckGlobeNewsWire • 07/26/22
Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCsGlobeNewsWire • 07/12/22
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)GlobeNewsWire • 06/27/22
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)PRNewsWire • 06/27/22
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/09/22
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated MilestonesGlobeNewsWire • 05/09/22
Is a Surprise Coming for Sutro Biopharma (STRO) This Earnings Season?Zacks Investment Research • 05/05/22
Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022PRNewsWire • 04/08/22
Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare ConferencePRNewsWire • 04/05/22